A phase II study of combined ridaforolimus and dalotuzumab compared with exemestane in patients with estrogen receptor-positive breast cancer.
| Image |  |
|---|---|
| Description | scientific article published on 21 March 2017 |
| Author/s |
author: Beverly Moy Serafin Morales Hope Rugo Peter Vuylsteke Joanne L Blum |
| Publication date | March 21, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |